598 related articles for article (PubMed ID: 35757002)
1. Tissue-Resident Innate Immune Cell-Based Therapy: A Cornerstone of Immunotherapy Strategies for Cancer Treatment.
Busà R; Bulati M; Badami E; Zito G; Maresca DC; Conaldi PG; Ercolano G; Ianaro A
Front Cell Dev Biol; 2022; 10():907572. PubMed ID: 35757002
[TBL] [Abstract][Full Text] [Related]
2. Orchestration of immune response by innate lymphoid cell subtype 2 at various tumor microenvironment, a suitable target for cancer immunotherapy.
Roy R; Das T; Biswas N
Int Rev Immunol; 2024; 43(2):74-82. PubMed ID: 37599626
[TBL] [Abstract][Full Text] [Related]
3. The Role of Innate Lymphoid Cells in Cancer Development and Immunotherapy.
Sugimura R; Wang CY
Front Cell Dev Biol; 2022; 10():803563. PubMed ID: 35557940
[TBL] [Abstract][Full Text] [Related]
4. Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions.
Mariotti FR; Quatrini L; Munari E; Vacca P; Moretta L
Front Immunol; 2019; 10():910. PubMed ID: 31105707
[TBL] [Abstract][Full Text] [Related]
5. Exploiting innate immunity for cancer immunotherapy.
Yi M; Li T; Niu M; Mei Q; Zhao B; Chu Q; Dai Z; Wu K
Mol Cancer; 2023 Nov; 22(1):187. PubMed ID: 38008741
[TBL] [Abstract][Full Text] [Related]
6. Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy.
Zalfa C; Paust S
Front Immunol; 2021; 12():633205. PubMed ID: 34025641
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory functions of innate lymphoid cells.
Crome SQ; Ohashi PS
J Immunother Cancer; 2018 Nov; 6(1):121. PubMed ID: 30454038
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells.
Munari E; Quatrini L; Ciancaglini C; Eccher A; Bogina G; Moretta L; Mariotti FR
Semin Immunol; 2022 Nov; 61-64():101660. PubMed ID: 36370672
[TBL] [Abstract][Full Text] [Related]
9. NK cells and ILCs in tumor immunotherapy.
Sivori S; Pende D; Quatrini L; Pietra G; Della Chiesa M; Vacca P; Tumino N; Moretta F; Mingari MC; Locatelli F; Moretta L
Mol Aspects Med; 2021 Aug; 80():100870. PubMed ID: 32800530
[TBL] [Abstract][Full Text] [Related]
10. Innate Lymphoid Cells in Bladder Cancer: From Mechanisms of Action to Immune Therapies.
Noel ODV; Hassouneh Z; Svatek RS; Mukherjee N
Cancer Immunol Res; 2024 Feb; 12(2):149-160. PubMed ID: 38060011
[TBL] [Abstract][Full Text] [Related]
11. Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunity.
Ruf B; Greten TF; Korangy F
Nat Rev Cancer; 2023 Jun; 23(6):351-371. PubMed ID: 37081117
[TBL] [Abstract][Full Text] [Related]
12. Dichotomous Regulation of Acquired Immunity by Innate Lymphoid Cells.
Ebihara T
Cells; 2020 May; 9(5):. PubMed ID: 32403291
[TBL] [Abstract][Full Text] [Related]
13. Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes.
Pesce S; Trabanelli S; Di Vito C; Greppi M; Obino V; Guolo F; Minetto P; Bozzo M; Calvi M; Zaghi E; Candiani S; Lemoli RM; Jandus C; Mavilio D; Marcenaro E
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33255582
[TBL] [Abstract][Full Text] [Related]
14. The depths of PD-1 function within the tumor microenvironment beyond CD8
Laba S; Mallett G; Amarnath S
Semin Cancer Biol; 2022 Nov; 86(Pt 2):1045-1055. PubMed ID: 34048897
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor Microenvironment.
Carnevalli LS; Ghadially H; Barry ST
Front Immunol; 2021; 12():633685. PubMed ID: 33953710
[TBL] [Abstract][Full Text] [Related]
16. Helper Innate Lymphoid Cells-Unappreciated Players in Melanoma Therapy.
Garofalo C; Cerantonio A; Muscoli C; Mollace V; Viglietto G; De Marco C; Cristiani CM
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765891
[TBL] [Abstract][Full Text] [Related]
17. Protocols for Innate Lymphoid Cell Phenotypic and Functional Characterization: An Overview.
Amarnath S
Methods Mol Biol; 2020; 2121():1-6. PubMed ID: 32147781
[TBL] [Abstract][Full Text] [Related]
18. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
Seledtsov VI; Goncharov AG; Seledtsova GV
Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
[TBL] [Abstract][Full Text] [Related]
19. Innate Lymphoid Cells in Protection, Pathology, and Adaptive Immunity During Apicomplexan Infection.
Ivanova DL; Denton SL; Fettel KD; Sondgeroth KS; Munoz Gutierrez J; Bangoura B; Dunay IR; Gigley JP
Front Immunol; 2019; 10():196. PubMed ID: 30873151
[TBL] [Abstract][Full Text] [Related]
20. Humanized Mouse Models for the Advancement of Innate Lymphoid Cell-Based Cancer Immunotherapies.
Horowitz NB; Mohammad I; Moreno-Nieves UY; Koliesnik I; Tran Q; Sunwoo JB
Front Immunol; 2021; 12():648580. PubMed ID: 33968039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
